Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €83.10 | €100.00 | 20.337% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €90.50 | €124.85 | 37.953% |
| LivaNova plc | 9 | 0 | 3 | 0 | €57.00 | €66.59 | 16.829% |
| Heidelberg Pharma AG | 3 | 0 | 0 | 0 | €2.99 | - | - |
| Stryker Corp. | 23 | 0 | 9 | 0 | €305.20 | €335.03 | 9.773% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €70.18 | €80.00 | 13.993% |
| Geron Corp. | 12 | 0 | 4 | 0 | €3.65 | €4.63 | 26.838% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| Fate Therapeutics Inc. | 5 | 2 | 2 | 1 | €3.78 | €8.27 | 118.625% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €72.00 | €75.94 | 5.467% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €73.50 | €79.00 | 7.483% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €216.90 | €247.61 | 14.157% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €189.00 | - | - |
| Lightpath Techs A | 3 | 0 | 0 | 0 | €1.29 | €2.78 | 115.783% |
| Cutera Inc. | 2 | 0 | 1 | 0 | €2.36 | €3.75 | 59.236% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €20.62 | €26.01 | 26.122% |
| Vitrolife AB | 3 | 0 | 0 | 0 | €15.09 | - | - |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €24.60 | €26.58 | 8.054% |
| Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €22.80 | €35.43 | 55.392% |
| Neurocrine Bioscience | 27 | 0 | 7 | 0 | €130.70 | €140.34 | 7.376% |
| Community Health Systems Inc. | 4 | 3 | 1 | 0 | €3.04 | €5.36 | 76.461% |
| AnaptysBio Inc | 8 | 1 | 3 | 0 | €24.80 | €46.24 | 86.452% |
| Lemaitre Vascular Inc | 1 | 0 | 0 | 0 | €61.50 | - | - |
| ShockWave Medical Inc | 1 | 0 | 0 | 0 | €307.00 | - | - |
| X4 Pharmaceuticals, Inc. | 6 | 1 | 3 | 1 | €1.07 | €2.78 | 158.705% |